Victory Capital Management
CTXR icon

Victory Capital Management’s Citius Pharmaceuticals CTXR Stock Holding History

Victory Capital Management’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-855
Closed -$10.7K – 2487
2024
Q3 		$10.7K Sell
855
-15
-2% -$252 ﹤0.01% 2471
2024
Q2 		$12.7K Buy
870
+97
+13% +$1.74K ﹤0.01% 2457
2024
Q1 		$17.3K Sell
773
-17
-2% -$310 ﹤0.01% 2452
2023
Q4 		$14.9K Buy
790
+148
+23% +$2.81K ﹤0.01% 2520
2023
Q3 		$11K Buy
642
+53
+9% +$1.26K ﹤0.01% 2483
2023
Q2 		$17.7K Sell
589
-14
-2% -$461 ﹤0.01% 2456
2023
Q1 		$17.6K Buy
+603
New +$17.4K ﹤0.01% 2518

Other funds holding CTXR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.13B AUM 23.41% 1-Year Est. Return

Victory Capital Management's CTXR Position: Q4 2024 in Review

Victory Capital Management sold out of Citius Pharmaceuticals (CTXR) in Q4 2024, closing a stake of 855 shares — an estimated $10.7K sold.

Victory Capital Management first reported a position in CTXR in Q1 2023 and held it in 7 quarters. The position peaked at $17.7K in Q2 2023. 30 funds tracked by Wall St. Rank hold CTXR as of Q4 2024.

  • Victory Capital Management reported no remaining Citius Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Victory Capital Management sold 855 Citius Pharmaceuticals shares in Q4 2024, an estimated $10.7K.
  • Victory Capital Management first reported a position in Citius Pharmaceuticals in Q1 2023 and held it in 7 quarters.
  • Victory Capital Management's Citius Pharmaceuticals position peaked at $17.7K in Q2 2023.
  • 30 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q4 2024.

Based on Victory Capital Management's 13F filing for Q4 2024, filed 6 Feb 2025.